Development of an antisense oligonucleotides-based therapy for mucolipidosis type II α/β: in vivo studies

Introduction: The RNA molecule has become an increasingly promising target for the therapy of various diseases. Mucolipidosis type II α/β (ML II α/β) is one of the most severe Lysosomal Storage Disorders and is caused by the deficiency of the enzyme GlcNAc-1- phosphotransferase. This enzyme is respo...

ver descrição completa

Detalhes bibliográficos
Autor principal: Gonçalves, Mariana (author)
Outros Autores: Matos, Liliana (author), Santos, Juliana Inês (author), Coutinho, Maria Francisca (author), Prata, Maria João (author), Pires, Maria João (author), Oliveira, Paula (author), Alves, Sandra (author)
Formato: conferenceObject
Idioma:eng
Publicado em: 2022
Assuntos:
Doenças Genéticas
Genética Humana
Doenças Lisossomais de sobrecarga
Mucolipidose tipo II
Texto completo:http://hdl.handle.net/10400.18/8191
País:Portugal
Oai:oai:repositorio.insa.pt:10400.18/8191

Texto Completo

http://hdl.handle.net/10400.18/8191

Registros relacionados